• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

系统性硬化症患者小肠细菌过度生长的患病率及相关因素

Prevalence and associated factors of small intestinal bacterial overgrowth among systemic sclerosis patients.

作者信息

Sawadpanich Kookwan, Soison Pisit, Chunlertrith Kitti, Mairiang Pisaln, Sukeepaisarnjaroen Wattana, Sangchan Apichat, Suttichaimongkol Tanita, Foocharoen Chingching

机构信息

Faculty of Medicine, Division of Gastroenterology, Department of Medicine, Khon Kaen University, Khon Kaen, Thailand.

Faculty of Medicine, Division of Allergy-Immunology-Rheumatology, Department of Medicine, Khon Kaen University, Khon Kaen, Thailand.

出版信息

Int J Rheum Dis. 2019 Apr;22(4):695-699. doi: 10.1111/1756-185X.13495. Epub 2019 Feb 6.

DOI:10.1111/1756-185X.13495
PMID:30729669
Abstract

BACKGROUND

Small intestinal bacterial overgrowth (SIBO) results in nutrient malabsorption and malnutrition, thereby increasing the morbidity and mortality in systemic sclerosis (SSc) patients.

OBJECTIVES

To evaluate the prevalence and associated factors of SIBO in SSc patients.

METHOD

A cross-sectional study was conducted between July 2015 and January 2016 in SSc patients over 18, using the glucose H /CH breath test to evaluate SIBO.

RESULTS

Eighty-nine SSc patients (30 male and 59 female) underwent the glucose H /CH breath test. The mean age was 54.4. Twelve participants were positive for the glucose H /CH breath test, yielding a SIBO prevalence of 13.5% (95% CI 7.2-22.4) among SSc patients. A multivariate analysis revealed that duration of disease >5 years was significantly associated with SIBO (adjusted odds ratio 9.38; 95% CI 1.09-80.47).

CONCLUSION

The prevalence of SIBO, using the glucose H /CH breath test, is not common among Thai SSc patients. However, a positive result was associated with longer duration of disease.

摘要

背景

小肠细菌过度生长(SIBO)会导致营养吸收不良和营养不良,从而增加系统性硬化症(SSc)患者的发病率和死亡率。

目的

评估SSc患者中SIBO的患病率及相关因素。

方法

2015年7月至2016年1月对18岁以上的SSc患者进行了一项横断面研究,采用葡萄糖氢/甲烷呼气试验评估SIBO。

结果

89例SSc患者(30例男性和59例女性)接受了葡萄糖氢/甲烷呼气试验。平均年龄为54.4岁。12名参与者的葡萄糖氢/甲烷呼气试验呈阳性,SSc患者中SIBO的患病率为13.5%(95%CI 7.2-22.4)。多因素分析显示,病程>5年与SIBO显著相关(校正比值比9.38;95%CI 1.09-80.47)。

结论

在泰国SSc患者中,采用葡萄糖氢/甲烷呼气试验得出的SIBO患病率并不常见。然而,阳性结果与病程较长有关。

相似文献

1
Prevalence and associated factors of small intestinal bacterial overgrowth among systemic sclerosis patients.系统性硬化症患者小肠细菌过度生长的患病率及相关因素
Int J Rheum Dis. 2019 Apr;22(4):695-699. doi: 10.1111/1756-185X.13495. Epub 2019 Feb 6.
2
Small intestinal bacterial overgrowth in systemic sclerosis.系统性硬化症中的小肠细菌过度生长
Rheumatology (Oxford). 2009 Oct;48(10):1314-9. doi: 10.1093/rheumatology/kep226. Epub 2009 Aug 20.
3
Small-Intestinal Bacterial Overgrowth is Associated With Concurrent Intestinal Inflammation But Not With Systemic Inflammation in Crohn's Disease Patients.小肠细菌过度生长与克罗恩病患者的肠道炎症同时发生有关,但与全身炎症无关。
J Clin Gastroenterol. 2018 Jul;52(6):530-536. doi: 10.1097/MCG.0000000000000803.
4
Prevalence and predictors of small intestinal bacterial overgrowth in systemic sclerosis patients with gastrointestinal symptoms.有胃肠道症状的系统性硬化症患者小肠细菌过度生长的患病率及预测因素
Clin Exp Rheumatol. 2014 Nov-Dec;32(6 Suppl 86):S-82-7. Epub 2014 Nov 3.
5
Small intestinal bacterial overgrowth in patients suffering from scleroderma: clinical effectiveness of its eradication.硬皮病患者的小肠细菌过度生长:根除治疗的临床效果
Am J Gastroenterol. 2008 May;103(5):1257-62. doi: 10.1111/j.1572-0241.2007.01758.x. Epub 2008 Apr 16.
6
What tests should you use to assess small intestinal bacterial overgrowth in systemic sclerosis?你应该使用哪些测试来评估系统性硬化症中的小肠细菌过度生长?
Clin Exp Rheumatol. 2015 Jul-Aug;33(4 Suppl 91):S117-22. Epub 2015 Aug 31.
7
Fecal calprotectin in systemic sclerosis and review of the literature.系统性硬皮病中的粪便钙卫蛋白及文献复习。
Autoimmun Rev. 2015 Jun;14(6):547-54. doi: 10.1016/j.autrev.2015.01.018. Epub 2015 Feb 4.
8
Prevalence and predictors of small intestinal bacterial overgrowth in systemic sclerosis: a systematic review and meta-analysis.系统性硬化症中小肠细菌过度生长的患病率和预测因素:系统评价和荟萃分析。
Clin Rheumatol. 2021 Aug;40(8):3039-3051. doi: 10.1007/s10067-020-05549-8. Epub 2021 Jan 11.
9
Small intestinal bacterial overgrowth in patients with chronic pancreatitis.慢性胰腺炎患者的小肠细菌过度生长
J Clin Gastroenterol. 2014 Nov-Dec;48 Suppl 1:S52-5. doi: 10.1097/MCG.0000000000000238.
10
Association of Small Intestinal Bacterial Overgrowth With Heart Failure and Its Prediction for Short-Term Outcomes.小肠细菌过度生长与心力衰竭的关联及其对短期预后的预测。
J Am Heart Assoc. 2021 Apr 6;10(7):e015292. doi: 10.1161/JAHA.119.015292. Epub 2021 Mar 17.

引用本文的文献

1
A scoping review of the epidemiology of systemic sclerosis and its organ manifestations: 2018-2024.系统性硬化症及其器官表现的流行病学范围综述:2018 - 2024年
Curr Opin Rheumatol. 2025 Mar 1;37(2):103-112. doi: 10.1097/BOR.0000000000001063. Epub 2024 Oct 23.
2
Small Intestinal Bacterial Overgrowth (SIBO) and Twelve Groups of Related Diseases-Current State of Knowledge.小肠细菌过度生长(SIBO)与十二组相关疾病——当前知识状况
Biomedicines. 2024 May 7;12(5):1030. doi: 10.3390/biomedicines12051030.
3
Managing gastrointestinal manifestations in systemic sclerosis, a mechanistic approach.
系统性硬化症胃肠道表现的管理:一种基于机制的方法。
Expert Rev Clin Immunol. 2024 Jun;20(6):603-622. doi: 10.1080/1744666X.2024.2320205. Epub 2024 Feb 26.
4
Epidemiology of small intestinal bacterial overgrowth.小肠细菌过度生长的流行病学。
World J Gastroenterol. 2023 Jun 14;29(22):3400-3421. doi: 10.3748/wjg.v29.i22.3400.
5
Small Intestinal Bacterial Overgrowth Complicating Gastrointestinal Manifestations of Systemic Sclerosis: A Systematic Review and Meta-analysis.小肠细菌过度生长并发系统性硬化症的胃肠道表现:一项系统评价和荟萃分析
J Neurogastroenterol Motil. 2023 Apr 30;29(2):132-144. doi: 10.5056/jnm22168.
6
Show Me What You Have Inside-The Complex Interplay between SIBO and Multiple Medical Conditions-A Systematic Review.展示你内心的世界——小肠细菌过度生长与多种医疗状况的复杂相互作用:系统评价。
Nutrients. 2022 Dec 24;15(1):90. doi: 10.3390/nu15010090.
7
Asian-Pacific consensus on small intestinal bacterial overgrowth in gastrointestinal disorders: An initiative of the Indian Neurogastroenterology and Motility Association.亚太地区胃肠疾病小肠细菌过度生长共识:印度神经胃肠病学和动力学会的倡议。
Indian J Gastroenterol. 2022 Oct;41(5):483-507. doi: 10.1007/s12664-022-01292-x. Epub 2022 Oct 10.
8
Management of scleroderma gastrointestinal disease: Lights and shadows.硬皮病胃肠道疾病的管理:光明与阴影
J Scleroderma Relat Disord. 2022 Jun;7(2):85-97. doi: 10.1177/23971983221086343. Epub 2022 Apr 19.
9
Gastrointestinal manifestations of systemic sclerosis: An updated review.系统性硬化症的胃肠道表现:最新综述
World J Clin Cases. 2021 Aug 6;9(22):6201-6217. doi: 10.12998/wjcc.v9.i22.6201.
10
Clinical Assessment of Gastrointestinal Involvement in Patients with Systemic Sclerosis.系统性硬化症患者胃肠道受累情况的临床评估
Med Res Arch. 2020 Oct;8(10). doi: 10.18103/mra.v8i10.2252. Epub 2020 Oct 29.